Discovery and quantitation of novel liver fibrosis biomarkers in hepatitis C patients
Liver biopsy is the reference standard for assessing liver fibrosis and no reliable serum biomarkers are available to discriminate between the intermediate stages of fibrosis. We used proteomics to identify novel fibrosis biomarkers in hepatitis C patients with different degrees of liver fibrosis.
| 主要作者: | |
|---|---|
| 格式: | Conference item |
| 出版: |
OMICS International
2017
|